Načítá se...
FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer
PURPOSE: Therapy response to neoadjuvant radiochemotherapy (nRCT) of locally advanced rectal cancer varies widely so that markers predicting response are urgently needed. Fibroblast growth factor (FGF) and FGF receptor (FGFR) signaling is involved in pro-survival signaling and thereby may result in...
Uloženo v:
| Vydáno v: | J Cancer Res Clin Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6326005/ https://ncbi.nlm.nih.gov/pubmed/30276721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-018-2757-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|